Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer's disease brain

Neuron. 1995 Jul;15(1):219-28. doi: 10.1016/0896-6273(95)90079-9.

Abstract

Genetic evidence suggests a role for apolipoprotein E (apoE) in Alzheimer's disease (AD) amyloidogenesis. Here, amyloid-associated apoE from 32 AD patients was purified and characterized. We found that brain amyloid-associated apoE apparently exists not as free molecules but as complexes with polymers of the amyloid beta peptide (A beta). Brain A beta-apoE complexes were detected irrespective of the apoE genotype, and similar complexes could be mimicked in vitro. The fine structure of purified A beta-apoE complexes was fibrillar, and immunogold labeling revealed apoE immunoreactivity along the fibrils. Thus, we conclude that A beta-apoE complexes are principal components of AD-associated brain amyloid and that the data presented here support a role for apoE in the pathogenesis of AD.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / immunology
  • Alzheimer Disease / metabolism*
  • Amyloid beta-Peptides / isolation & purification
  • Amyloid beta-Peptides / metabolism*
  • Amyloid beta-Peptides / ultrastructure
  • Apolipoproteins E / isolation & purification
  • Apolipoproteins E / metabolism*
  • Apolipoproteins E / ultrastructure
  • Brain Chemistry*
  • Humans
  • Immunohistochemistry
  • Microscopy, Electron
  • Middle Aged
  • Protein Binding / physiology

Substances

  • Amyloid beta-Peptides
  • Apolipoproteins E